NCT05932849 - Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres | Biotech Hunter

Enrollment

276

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions

Asthma

Interventions

DRUG

Benralizumab

Patients were initiated on benralizumab as part of routine clinical practice

Trial Locations (8)

Addenbrookes Hospital, Cambridge

Castle Hill Hospital, Hull

St James's University Hospital, Leeds

Royal Liverpool University Hospital, Liverpool

Guy's Hospital, London

Royal Brompton Hospital, London

St Bartholomew's Hospital, London

Southampton General Hospital, Southampton